Consun Pharmaceutical Group Limited
CPHGF
$1.08
$0.0747.34%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 126.61M | 121.35M | 115.82M | 113.05M | 110.63M |
| Total Depreciation and Amortization | 8.89M | 9.94M | 10.98M | 10.99M | 11.04M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.70M | -1.67M | 2.31M | -982.40K | -4.45M |
| Change in Net Operating Assets | 21.44M | 9.55M | -2.40M | -2.40M | -2.40M |
| Cash from Operations | 151.24M | 139.16M | 126.72M | 120.65M | 114.81M |
| Capital Expenditure | -15.16M | -13.32M | -11.46M | -9.41M | -7.37M |
| Sale of Property, Plant, and Equipment | 45.30K | 56.20K | 67.10K | 44.00K | 20.90K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.83M | -32.07M | -53.26M | -38.86M | -24.23M |
| Cash from Investing | -25.94M | -45.33M | -64.65M | -48.23M | -31.58M |
| Total Debt Issued | 497.55M | 434.33M | 371.11M | 406.75M | 442.39M |
| Total Debt Repaid | -758.20M | -570.25M | -382.31M | -382.62M | -382.93M |
| Issuance of Common Stock | 142.99M | 136.06M | 129.13M | 71.67M | 14.20M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -94.54M | -86.71M | -78.78M | -62.54M | -46.39M |
| Other Financing Activities | 68.94M | 17.53M | -33.89M | -30.70M | -27.51M |
| Cash from Financing | -101.40M | -84.34M | -67.12M | -53.33M | -39.58M |
| Foreign Exchange rate Adjustments | -1.59M | -1.64M | -1.70M | -1.47M | -1.23M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.32M | 7.85M | -6.74M | 17.63M | 42.41M |